Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-24 @ 6:25 PM
Study NCT ID:
NCT04285268
Status:
WITHDRAWN
Last Update Posted:
2020-06-16
First Post:
2020-02-24
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Rutgers, The State University of New Jersey
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-24
First Submit QC Date:
None
Study First Post Date:
2020-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-12
Last Update Post Date:
2020-06-16
Last Update Post Date Type:
ACTUAL